March 22, 2023 — Ancora Heart, Inc., a privately-held Santa Clara, CA-based company developing a completely transcatheter device-based therapy to address heart failure (HF), has announced that patients treated with the investigational AccuCinch Ventricular Restoration System demonstrated improvement in HF patient outcomes and beneficial changes in the structure of the heart.

March 21, 2023 — As part of its extensive coverage, the editorial team at dicardiology.com/DAIC has shared summary highlights from the 72nd Convocation of the American College of Cardiology’s Annual Scientific Session, which took place on the final day of the ACC Together with the World Congress of Cardiology (ACC.23/WCC).

March 21, 2023 —  Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today that use of its Aortix percutaneous mechanical circulatory support (pMCS) device led to rapid decongestion in a pilot study of

ACC's 73rd Annual Scientific Session & Expo

March 21, 2023 — The first platform to combine real-world cardiology data from millions of people in multiple European countries is set to advance research aimed at improving heart health. The EU-funded DataTools4Heart (DT4H) project is backed by the European Society of Cardiology (ESC) and coordinated by the Artificial Intelligence in Medicine lab (BCN-AIM), University of Barcelona, Spain.1

The Healthcare Information and Management Systems Society (HIMSS) annual conference will take place April 17-21, 2023, at McCormick Place in Chicago

The theme of The Healthcare Information and Management Systems Society (HIMSS23) is Health That Connects + Tech That Cares, which suggests that there's an active balance behind every decision that is made in healthcare, and every step that is taken to execute that decision, giving equal weight to both.

March 20, 2023 — University of Utah Health scientists have corrected abnormal heart rhythms in mice by restoring healthy levels of a protein that heart cells need to establish connections with one another. That protein, GJA1-20k, is underproduced in people with a genetic condition called arrhythmogenic cardiomyopathy, one of the leading causes of sudden cardiac arrest in athletes under the age of 35.

March 17, 2023 — More donated hearts could be suitable for transplantation if they are kept functioning within the body for a short time following the death of the donor, new research has concluded.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now